$179 Million is the total value of Krensavage Asset Management, LLC's 26 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | New | UNITED THERAPEUTICS CORP | $16,160,000 | – | 124,801 | +100.0% | 9.00% | – |
| AMAG | New | AMAG PHARMACEUTICALS INC | $14,876,000 | – | 349,042 | +100.0% | 8.29% | – |
| SCMP | New | SUCAMPO PHARMACEUTICALS-CL A | $13,681,000 | – | 958,048 | +100.0% | 7.62% | – |
| IPXL | New | IMPAX LABORATORIES INC | $13,406,000 | – | 423,161 | +100.0% | 7.47% | – |
| TEVA | New | TEVA PHARMACEUTICAL-SP ADR | $12,606,000 | – | 219,200 | +100.0% | 7.02% | – |
| HYH | New | HALYARD HEALTH INC | $12,161,000 | – | 267,450 | +100.0% | 6.78% | – |
| CNMD | New | CONMED CORP | $11,605,000 | – | 258,117 | +100.0% | 6.47% | – |
| MRK | New | MERCK & CO. INC. | $11,591,000 | – | 204,100 | +100.0% | 6.46% | – |
| OFIX | New | ORTHOFIX INTERNATIONAL NV | $9,393,000 | – | 312,470 | +100.0% | 5.23% | – |
| HRC | New | HILL-ROM HOLDINGS INC | $8,946,000 | – | 196,100 | +100.0% | 4.98% | – |
| RTIX | New | RTI SURGICAL INC | $8,588,000 | – | 1,651,458 | +100.0% | 4.78% | – |
| DEPO | New | DEPOMED INC | $6,163,000 | – | 382,542 | +100.0% | 3.43% | – |
| B108PS | New | ACTAVIS PLC | $5,925,000 | – | 23,016 | +100.0% | 3.30% | – |
| IVC | New | INVACARE CORP | $5,611,000 | – | 334,762 | +100.0% | 3.13% | – |
| MNKKQ | New | MALLINCKRODT PLC | $4,991,000 | – | 50,395 | +100.0% | 2.78% | – |
| ABBV | New | ABBVIE INC | $4,941,000 | – | 75,500 | +100.0% | 2.75% | – |
| New | AMGEN INC | $4,619,000 | – | 29,000 | +100.0% | 2.57% | – | |
| MDCO | New | MEDICINES COMPANY | $3,558,000 | – | 128,600 | +100.0% | 1.98% | – |
| New | BIOTA PHARMACEUTICALS INC | $2,570,000 | – | 1,147,130 | +100.0% | 1.43% | – | |
| THRX | New | THERAVANCE INC | $2,432,000 | – | 171,859 | +100.0% | 1.36% | – |
| DRAD | New | DIGIRAD CORP | $1,829,000 | – | 419,604 | +100.0% | 1.02% | – |
| CBRX | New | COLUMBIA LABORATORIES INC | $1,770,000 | – | 316,149 | +100.0% | 0.99% | – |
| FURX | New | FURIEX PHARMACEUTICA CMN | $1,422,000 | – | 145,544 | +100.0% | 0.79% | – |
| PFE | New | PFIZER INC | $419,000 | – | 13,447 | +100.0% | 0.23% | – |
| LLY | New | ELI LILLY & CO | $148,000 | – | 2,143 | +100.0% | 0.08% | – |
| QLTI | New | QLT INC | $68,000 | – | 17,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.